ClinicalTrials.gg
Not yet recruitingNCT07693504Updated Jul 13, 2026

Weekend Warrior Exercise in Sedentary Female University Students

An interventional study of Weekend Warrior Exercise and Regularly Distributed Exercise in Sedentary Behavior, sponsored by Chongqing Normal University. Not yet recruiting at 1 site in China. Open to female participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-13.

Sponsored by Chongqing Normal University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
Female
01

Study summary

This single-center, single-blind, three-arm randomized controlled trial aims to compare the effects of weekend-concentrated exercise, regularly distributed exercise, and usual lifestyle on aerobic capacity and skeletal muscle strength in sedentary female university students. Sixty participants aged 18 to 25 years will be randomly assigned in a 1:1:1 ratio to a weekend warrior group, a regular exercise group, or a control group.

The intervention will last 8 weeks. Both exercise groups will complete 150 minutes of moderate-intensity exercise per week, combining resistance exercise and jogging, but the exercise sessions will be distributed differently across the week. The control group will maintain its usual lifestyle without receiving the prescribed exercise intervention.

The primary outcomes are peak oxygen uptake and isokinetic peak torque. Secondary outcomes include body composition, maximal heart rate, maximal power and time to exhaustion, 12-minute run performance, isokinetic mean torque, physical activity, sleep quality, exercise self-efficacy, emotional status, cognitive function, adherence, feasibility, and exercise-related adverse events.

Read the detailed description

This study is designed to test whether concentrating the recommended weekly exercise volume into a weekend pattern produces comparable benefits to a regularly distributed exercise pattern in sedentary female university students. The intervention emphasizes a dose-matched comparison in which both exercise groups complete the same total weekly exercise duration, while the distribution of exercise sessions differs.

After baseline screening and assessment, participants will be assigned to one of three parallel groups using a 1:1:1 allocation ratio. The weekend warrior group will complete two consecutive exercise days per week, whereas the regularly distributed exercise group will complete three exercise days per week. Both exercise programs will last 8 weeks and include resistance exercise combined with moderate-intensity jogging.

Resistance exercise will primarily target the lower limbs, core, and major muscle groups. Exercises may include squats, lunges, glute bridges, calf raises, and planks, using body weight, elastic bands, or light equipment as appropriate. Jogging may be performed as continuous jogging or a run-walk format according to individual fitness level. Exercise intensity will be monitored using heart rate and rating of perceived exertion. Jogging intensity will generally be maintained at approximately 60% to 75% of maximal heart rate or a rating of perceived exertion of 12 to 14. Each session will include warm-up, supervised exercise, and cool-down activities.

The main contrast between the two exercise interventions is the weekly distribution of exercise rather than total weekly duration. The control group will maintain usual study and lifestyle habits during the 8-week period. Study staff will monitor adherence, perceived exertion, discomfort, and exercise-related events during the intervention. Outcome assessors will be blinded to group allocation when feasible.

02

Conditions studied

  • Sedentary Behavior

Browse trials for

Keywords

  • Weekend Warrior Exercise
  • Aerobic Capacity
  • Skeletal Muscle Strength
  • Female University Students
  • Exercise Distribution
  • Moderate-Intensity Exercise
03

In context

Sedentary Behavior

1,273 studies on the registry are indexed under Sedentary Behavior; 300 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 1,076 interventional studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

Chongqing Normal University is the lead sponsor of 5 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female university students aged 18 to 25 years.
  • Self-reported sedentary time of at least 6 hours per day, further assessed using the International Physical Activity Questionnaire (IPAQ).
  • No cardiovascular, pulmonary, neurological, metabolic, or musculoskeletal diseases.
  • Relatively regular menstrual cycles.
  • Able to understand the study procedures, willing to complete the intervention and assessments, and willing to provide written .

Exclusion criteria

Exclusion Criteria:

  • Any condition identified through clinical assessment or health screening that makes participation in moderate-intensity exercise or exercise-to-exhaustion testing inappropriate.
  • Participation in regular exercise training, a systematic weight-loss or body-shaping program, or another exercise intervention study within the previous 3 months.
  • Recent substantial body-weight fluctuations that may affect body-composition assessment.
  • Cardiovascular, pulmonary, neurological, metabolic, or musculoskeletal diseases, or current use of medications that may affect exercise performance, heart-rate responses, or muscle function.
  • Irregular menstrual cycles.
  • Inability to complete the 8-week intervention, post-intervention assessments, or required study records.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Weekend Warrior Exercise Group

    Participants will complete an 8-week weekend-concentrated exercise program. They will exercise on two consecutive days per week, completing 30 minutes of resistance exercise and 45 minutes of jogging on each exercise day, for a total of 75 minutes per day and 150 minutes per week.

    Behavioral: Weekend Warrior Exercise

  • Active comparator
    Regular Exercise Group

    Participants will complete an 8-week regularly distributed exercise program. They will exercise on three days per week, completing 20 minutes of resistance exercise and 30 minutes of jogging during each session, for a total of 50 minutes per session and 150 minutes per week.

    Behavioral: Regularly Distributed Exercise

  • No intervention
    Control Group

    Participants will maintain their usual study and lifestyle habits during the 8-week study period and will not receive the exercise intervention prescribed by the study. Their participation in additional structured exercise will be monitored.

Interventions

  • BehavioralWeekend Warrior Exercise

    Participants will complete an 8-week weekend-concentrated exercise program on two consecutive days per week. On each exercise day, participants will perform 30 minutes of resistance exercise and 45 minutes of moderate-intensity jogging, resulting in 75 minutes per day and 150 minutes per week. Resistance exercises will target the lower limbs, core, and major muscle groups and may include squats, lunges, glute bridges, calf raises, and planks. Jogging intensity will be maintained at approximately 60% to 75% of maximal heart rate or a rating of perceived exertion of 12 to 14. Each session will include warm-up and cool-down activities.

  • BehavioralRegularly Distributed Exercise

    Participants will complete 150 minutes of moderate-intensity exercise per week for 8 weeks, distributed across three days. Each session will include 20 minutes of resistance exercise targeting the lower limbs, core, and major muscle groups, followed by 30 minutes of jogging. The exercise content, intensity-control principles, and safety requirements will be comparable to those of the weekend warrior group.

06

What researchers measure

Primary outcomes

  1. Change in Peak Oxygen Uptake (VO2peak)

    Peak oxygen uptake will be assessed during a graded cardiopulmonary exercise test. VO2peak will be recorded in milliliters of oxygen per kilogram of body mass per minute (mL/kg/min). The change from baseline to the end of the 8-week intervention will be compared among the three study groups.

    Time frame: Baseline (week 0) and post-intervention (week 8)

  2. Change in Isokinetic Peak Torque

    Skeletal muscle peak torque will be assessed using an isokinetic dynamometer and recorded in Newton-meters (N·m). The change from baseline to the end of the 8-week intervention will be compared among the three study groups.

    Time frame: Baseline (week 0) and post-intervention (week 8)

Secondary outcomes

  1. Change in Body Weight

    Body weight will be measured in kilograms (kg). The change from baseline to the end of the 8-week intervention will be compared among the three study groups.

    Time frame: Baseline (week 0) and post-intervention (week 8)

  2. Change in Body Mass Index

    Body mass index will be calculated as body weight in kilograms divided by height in meters squared (kg/m²). The change from baseline to week 8 will be compared among the three study groups.

    Time frame: Baseline (week 0) and post-intervention (week 8)

  3. Change in Body Fat Percentage

    Body fat percentage will be assessed using body composition analysis and reported as a percentage (%). The change from baseline to week 8 will be compared among the three study groups.

    Time frame: Baseline (week 0) and post-intervention (week 8)

  4. Change in Waist-to-Hip Ratio

    Waist-to-hip ratio will be calculated by dividing waist circumference by hip circumference. The change from baseline to week 8 will be compared among the three study groups.

    Time frame: Baseline (week 0) and post-intervention (week 8)

  5. Change in Maximal Heart Rate

    Maximal heart rate will be recorded during the graded exercise test and reported in beats per minute (bpm). The change from baseline to week 8 will be compared among the three study groups.

    Time frame: Baseline (week 0) and post-intervention (week 8)

  6. Change in Maximal Power at Exhaustion

    The maximal power output achieved during the graded exercise test will be recorded in watts (W). The change from baseline to week 8 will be compared among the three study groups.

    Time frame: Baseline (week 0) and post-intervention (week 8)

  7. Change in Time to Exhaustion

    Time to exhaustion during the graded exercise test will be recorded in seconds. The change from baseline to week 8 will be compared among the three study groups.

    Time frame: Baseline (week 0) and post-intervention (week 8)

  8. Change in 12-Minute Run Distance

    The total distance completed during the 12-minute run test will be recorded in meters (m). The change from baseline to week 8 will be compared among the three study groups.

    Time frame: Baseline (week 0) and post-intervention (week 8)

  9. Change in Isokinetic Mean Torque

    Mean torque will be assessed using an isokinetic dynamometer and reported in Newton-meters (N·m). The change from baseline to week 8 will be compared among the three study groups.

    Time frame: Baseline (week 0) and post-intervention (week 8)

  10. Change in Physical Activity Level Assessed by the International Physical Activity Questionnaire

    Physical activity level will be assessed using the International Physical Activity Questionnaire (IPAQ) and expressed as metabolic equivalent minutes per week (MET-min/week). Higher values indicate a greater level of physical activity.

    Time frame: Baseline (week 0) and post-intervention (week 8)

  11. Exercise Adherence

    Exercise adherence will be calculated as the number of completed prescribed exercise sessions divided by the total number of prescribed sessions, multiplied by 100, and reported as a percentage. This outcome will be assessed separately in the two exercise groups.

    Time frame: Throughout the 8-week intervention

07

Study locations

1 site
  • Chongqing Normal University
    Chongqing, Chongqing Municipality 401331, China
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared. Study findings will be reported only in aggregate or anonymized form in academic publications, conference presentations, and research reports, in accordance with the approved protocol and informed consent.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Oct 2027, 15 months later.

Of 733 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's planned 15 months is close to that.

Counting every sponsor, half of 741 studies reached it within 14 months; a quarter within 6 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 3, 2026
First posted
Jul 9, 2026
StartEst.
Jul 2026
Primary completionEst.
Oct 2027
CompletionEst.
Oct 2027
Last update
Jul 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07693504
Lead sponsor
Chongqing Normal University
Responsible party
Ziren Zhao (Graduate Student, Chongqing Normal University) — Principal investigator
First posted
Jul 9, 2026
Start date
Jul 2026 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Jul 13, 2026

Study contacts

Kaixiang Zhou
Contact
bsuzhoukaixiang@163.com
+86 17844597198
Kaixiang Zhou
principal investigator · Chongqing Normal University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion